儿童多系统炎症综合征心脏受累综述
该综述总结已发表文献中儿童多系统炎症综合征(MIS-C)的心脏表现。MIS-C通常在急性SARS-CoV-2感染后数周出现,以持续发热和胃肠道症状最常见,心脏受累包括心室功能障碍、冠状动脉扩张和动脉瘤、心律失常和传导异常。多数患者数天至数周内恢复,死亡率罕见,但中长期心血管后遗症尚不明确。
要点
- MIS-C心脏表现常见,包括心室功能障碍、冠状动脉扩张/动脉瘤、心律失常和传导异常。
- 重症可表现为血管扩张性或心源性休克,需液体复苏、正性肌力支持,最重者需机械通气和ECMO。
- 经验性治疗以免疫调节为主,常用静脉注射免疫球蛋白、类固醇等,多数患者数天至数周恢复。
核心结论
- MIS-C是一种与SARS-CoV-2感染相关的严重炎症性疾病,心脏受累常见,多数患者短期恢复良好,但中长期心血管后遗症尚不明确。
研究设计与样本
- 综述,总结已发表文献中关于MIS-C的数据,聚焦心脏并发症,并提供心脏评估和随访的临床考虑。
主要发现
- MIS-C通常在急性感染后数周发生,推测病因是对SARS-CoV-2感染失调的炎症反应。
- 持续发热和胃肠道症状是最常见的症状。
- 文献中已报告超过600例MIS-C病例,在美国黑人和西班牙裔儿童中似乎更常见。
- 心脏表现包括心室功能障碍、冠状动脉扩张和动脉瘤、心律失常和传导异常。
- 重症可表现为血管扩张性或心源性休克,需要液体复苏、正性肌力支持,最严重者需要机械通气和体外膜氧合。
关键数值与推荐
- 美国疾病控制与预防中心将本综合征定义为儿童多系统炎症综合征。
- 经验性治疗旨在通过免疫调节药物逆转炎症反应,静脉注射免疫球蛋白、类固醇和其他免疫调节剂已被频繁使用。
临床怎么用
- 对MIS-C患儿应进行心脏评估,包括心室功能、冠状动脉、心律失常和传导异常的检查。
- 重症患者需按血管扩张性或心源性休克处理,给予液体复苏和正性肌力支持,必要时机械通气和ECMO。
- 经验性使用静脉注射免疫球蛋白、类固醇等免疫调节药物以逆转炎症反应。
- 多数患者数天至数周内恢复,死亡率罕见,但需关注中长期心血管并发症并进行随访。
局限性
- MIS-C的患病率未知。
- 中长期后遗症,特别是心血管并发症,尚不明确。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Coronavirus disease 2019 (COVID-19) is an infectious disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with substantial cardiovascular implications. Although infection with SARS-CoV-2 is usually mild in children, some children later develop a severe inflammatory disease that can have manifestations similar to toxic shock syndrome or Kawasaki disease. This syndrome has been defined by the US Centers for Disease Control and Prevention as multisystem inflammatory syndrome in children. Although the prevalence is unknown, >600 cases have been reported in the literature. Multisystem inflammatory syndrome in children appears to be more common in Black and Hispanic children in the United States. Multisystem inflammatory syndrome in children typically occurs a few weeks after acute infection and the putative etiology is a dysregulated inflammatory response to SARS-CoV-2 infection. Persistent fever and gastrointestinal symptoms are the most common symptoms. Cardiac manifestations are common, including ventricular dysfunction, coronary artery dilation and aneurysms, arrhythmia, and conduction abnormalities. Severe cases can present as vasodilatory or cardiogenic shock requiring fluid resuscitation, inotropic support, and in the most severe cases, mechanical ventilation and extracorporeal membrane oxygenation. Empirical treatments have aimed at reversing the inflammatory response using immunomodulatory medications. Intravenous immunoglobulin, steroids, and other immunomodulatory agents have been used frequently. Most patients recover within days to a couple of weeks and mortality is rare, although the medium- and long-term sequelae, particularly cardiovascular complications, are not yet known. This review describes the published data on multisystem inflammatory syndrome in children, focusing on cardiac complications, and provides clinical considerations for cardiac evaluation and follow-up.
引用
- Alsaied T, Tremoulet AH, Burns JC, et al. Review of Cardiac Involvement in Multisystem Inflammatory Syndrome in Children. Circulation. 2020. PMID: 33166178. doi:10.1161/CIRCULATIONAHA.120.049836
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。